With a growing understanding of the role of inflammation in CNS neurodegenerative disorders such as Alzheimer's disease (AD), neuroinflammatory disease has discovered distinct immune responses involving the adaptive and innate immune systems at different stages of disease. These responses could be used as therapeutic targets as well as driving disease processes. Immunotherapeutic techniques that have proven effective in Alzheimer's disease are increasingly being applied to other neurodegenerative diseases. The function of particular immune cell populations in the pathophysiology of neurodegenerative disorders has received more attention in recent years. Researchers in the discipline are working to understand the molecular pathways that underpin neurodegenerative diseases, which is one of the most important concerns of our era.
Important Alert:
X
Title : Down’s syndrome (trisomy 21) and alzheimer disease: A common medical and scientific fight
London Jacqueline, Paris Diderot University, France
Title : Memory should be the primary endpoint in early AD
Matthias W Riepe, Ulm University, Germany
Title : Quality of life children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Electrophysiology and alzheimer's pathology: A scoping review on eeg correlations with CSF biomarkers
Charikleia Karastamati, University of Pavia, Italy
Title : The vital role of care homes in supporting individuals with neurological conditions
Akankunda Veronicah, Golden Age Elderly Homes Kampala, Uganda
Title : Semantic-based memory-encoding strategy in enhancing cognitive function and daily task performance for older adults with mild cognitive impairment: A pilot non-randomised
Karen P Y Liu, Western Sydney University, Hong Kong